What is the trade name for the drug combination of Triamterene and HCTZ?

Prepare for the PNN 7-Day Live Course Test with our comprehensive quiz. Enhance your skills with flashcards and multiple-choice questions, each with helpful hints and detailed explanations. Get ready to excel!

Multiple Choice

What is the trade name for the drug combination of Triamterene and HCTZ?

Explanation:
The drug combination of Triamterene and hydrochlorothiazide (HCTZ) is marketed under two trade names: Dyazide and Maxzide. Both of these products contain the same active ingredients—Triamterene, a potassium-sparing diuretic, and hydrochlorothiazide, a thiazide diuretic. Dyazide was one of the first combinations of these two medications approved for use and remains a well-known brand. Maxzide is another combination product that serves the same therapeutic purpose and is often prescribed for the management of hypertension and edema. The fact that both names are used for this combination emphasizes their common therapeutic application, providing physicians with options depending on formulary availability or specific patient needs. Thus, the correct answer reflects the existence of both trade names for the same drug combination, making it clear that patients may encounter either name when prescribed this medication.

The drug combination of Triamterene and hydrochlorothiazide (HCTZ) is marketed under two trade names: Dyazide and Maxzide. Both of these products contain the same active ingredients—Triamterene, a potassium-sparing diuretic, and hydrochlorothiazide, a thiazide diuretic.

Dyazide was one of the first combinations of these two medications approved for use and remains a well-known brand. Maxzide is another combination product that serves the same therapeutic purpose and is often prescribed for the management of hypertension and edema.

The fact that both names are used for this combination emphasizes their common therapeutic application, providing physicians with options depending on formulary availability or specific patient needs. Thus, the correct answer reflects the existence of both trade names for the same drug combination, making it clear that patients may encounter either name when prescribed this medication.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy